No photo of Klara Kvorning Ternov
20172023

Research activity per year

Personal profile

Expertises

Klara Kvorning Ternov received her medical degree from the University of Copenhagen in 2015 and received her PhD degree in 2021, titled “Patient-reported outcomes and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer”. Dr. Ternov is currently a resident at the Department of Urology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark.

Main research areas

Metastatic castration-resistant prostate cancer; Abiraterone; Enzalutamide; Androgens; Patient-reported outcomes; Metabolic side-effects.

Current research

Serum androgens as predictive biomarkers in metastatic castration-resistent prostate cancer.

Long-term metabolic effects and patient-reported outcome of abiraterone and enzalutamide in metastatic castration-resistent prostate cancer.

Potential conflicts of interest

None

Fingerprint

Dive into the research topics where Klara Kvorning Ternov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or